Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.
The number of international investors in life sciences start-ups in the Catalonia region in Spain has multiplied by ten in the last five years, according to a new report.
The US Supreme Court has refused to hear an appeal against a ruling that American pharmaceutical firm Merck & Co cannot collect $200 million in damages due to its misconduct during a trial.
US-based Locus Biosciences has announced it will license its CRISPR-Cas3 technology to Janssen, a subsidiary of American pharmaceutical company Johnson & Johnson, in a deal worth a potential $818 million.
Los Angeles-based law firm Pierce Bainbridge Beck Price & Hecht has hired two partners to its New York office.
The Supreme Court of India has ruled that biotechnology company Monsanto’s patent for genetically modified cotton seeds is valid and enforceable in the country.
Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
John Zurawski has joined Ballard Spahr as a partner in Philadelphia, after spending more than two years at McCarter & English.
Pfizer and Seattle-based biotech company Kineta Immuno-Oncology have signed a research and licensing agreement worth a potential $520 million.
Holland & Hart has added Rachel Carnaggio, of counsel, to its Denver office in Colorado.